PubRank

Gavin Hamilton

Author PubWeight™ 52.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 2008 4.13
2 Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 2009 3.31
3 Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 2011 3.08
4 Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011 2.75
5 Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 2011 2.42
6 T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging 2011 2.27
7 Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 2013 1.78
8 Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 2013 1.77
9 Combination of complex-based and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction. Magn Reson Med 2011 1.67
10 Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms. J Magn Reson Imaging 2011 1.66
11 Optimal phased-array combination for spectroscopy. Magn Reson Imaging 2008 1.48
12 Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics 2009 1.46
13 Ultrashort echo time spectroscopic imaging (UTESI) of cortical bone. Magn Reson Med 2007 1.43
14 The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology 2003 1.34
15 Altered adiposity after extremely preterm birth. Pediatr Res 2004 1.32
16 Magnetic resonance imaging of the knee with ultrashort TE pulse sequences. Magn Reson Imaging 2004 1.30
17 A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS 2005 1.25
18 Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease. World J Gastroenterol 2006 1.21
19 Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study. J Hepatol 2008 1.10
20 Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 2014 1.02
21 Robustness of fat quantification using chemical shift imaging. Magn Reson Imaging 2011 0.99
22 Effect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data-based, T1-independent, T2*-corrected, spectrum-modeled MRI. J Magn Reson Imaging 2013 0.94
23 Inter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects. J Magn Reson Imaging 2013 0.94
24 Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. J Magn Reson Imaging 2011 0.92
25 Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: relation to liver, muscle and regional body fat content. Atherosclerosis 2007 0.91
26 Excess visceral and hepatic adipose tissue in Turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content. J Clin Endocrinol Metab 2005 0.90
27 A quantitative approach to sequence and image weighting. J Comput Assist Tomogr 2010 0.90
28 Mapping the double bonds in triglycerides. Magn Reson Imaging 2011 0.87
29 Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2007 0.87
30 Evidence from in vivo 31-phosphorus magnetic resonance spectroscopy phosphodiesters that exhaled ethane is a biomarker of cerebral n-3 polyunsaturated fatty acid peroxidation in humans. BMC Psychiatry 2008 0.87
31 In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications. Liver Int 2005 0.85
32 Effect of echo-sampling strategy on the accuracy of out-of-phase and in-phase multiecho gradient-echo MRI hepatic fat fraction estimation. J Magn Reson Imaging 2013 0.85
33 Carbohydrate-induced manipulation of insulin sensitivity independently of intramyocellular lipids. Br J Nutr 2003 0.83
34 31P MR spectroscopy in assessment of response to antiviral therapy for hepatitis C virus-related liver disease. AJR Am J Roentgenol 2007 0.82
35 Brain cell membrane motion-restricted phospholipids in patients with schizophrenia who have seriously and dangerously violently offended. Prog Neuropsychopharmacol Biol Psychiatry 2007 0.82
36 Cross-sectional and longitudinal evaluation of liver volume and total liver fat burden in adults with nonalcoholic steatohepatitis. Abdom Imaging 2015 0.79
37 Assessing bioenergetic compromise in autism spectrum disorder with 31P magnetic resonance spectroscopy: preliminary report. J Child Neurol 2013 0.79
38 Brief report: approaches to 31P-MRS in awake, non-sedated children with and without autism spectrum disorder. J Autism Dev Disord 2012 0.78
39 Phosphorus-31 brain MR spectroscopy in women during and after pregnancy compared with nonpregnant control subjects. AJNR Am J Neuroradiol 2005 0.77
40 H MR spectroscopy in the evaluation of the severity of chronic liver disease. Radiology 2003 0.76
41 Duplication of roles. Nurs Stand 2017 0.75
42 Fat Quantification in the Abdomen. Top Magn Reson Imaging 2017 0.75